YOSHIO YAMAOKA to Biomarkers
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Biomarkers.
Connection Strength
1.022
-
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer. Helicobacter. 2025 Mar-Apr; 30(2):e70022.
Score: 0.462
-
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol. 2010 Dec; 5(12):1885-93.
Score: 0.172
-
Helicobacter pylori type 4 secretion systems as gastroduodenal disease markers. Sci Rep. 2021 02 25; 11(1):4584.
Score: 0.087
-
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One. 2020; 15(4):e0230064.
Score: 0.082
-
Helicobacter pylori Infection and Gastric Mucosal Atrophy in Two Ethnic Groups in Nepal. Asian Pac J Cancer Prev. 2015; 16(17):7911-6.
Score: 0.057
-
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol. 2014 Jan; 29(1):67-73.
Score: 0.053
-
Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol. 2013 May 14; 19(18):2806-10.
Score: 0.051
-
Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15; 877(11-12):1193-9.
Score: 0.038
-
Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
Score: 0.019